ePrints

A Phase I, Dose-Escalation Study of the Multitargeted Receptor Tyrosine Kinase Inhibitor, Golvatinib, in Patients with Advanced Solid Tumors

Lookup NU author(s): Professor Alastair GreystokeORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Molife LR, Dean E, BlancoCodesido M, Krebs MG, Brunetto A, Greystoke AP, Daniele G, Lee L, Kuznetsov G, Myint KT, deLasHeras B, Wood K, Ranson MR

Publication type: Article

Publication status: Published

Journal: Clinical Cancer Research

Year: 2014

Volume: 20

Issue: 24

Pages: 6284-6294

Print publication date: 15/12/2014

Online publication date: 02/10/2014

Acceptance date: 25/08/2014

ISSN (print): 1078-0432

ISSN (electronic): 1557-3265

Publisher: American Association for Cancer Research

URL: http://dx.doi.org/10.1158/1078-0432.CCR-14-0409

DOI: 10.1158/1078-0432.CCR-14-0409

Altmetrics

Share